Pricing Log in Create free account
Saturday 17 October 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

382.92 0.10 −0.03%
Market cap
$27.0B
P/E
48.7×
Fwd P/E
37.3×
Dividend yield
0.23%
F-score
8/9
Altman Z
13.89
Beneish M
−2.79
Dividend safety
100/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

West Pharmaceutical Services, Inc. (WST) Business Profile

Updated before January 2025

Company Overview

West Pharmaceutical Services, Inc. (WST) is a global leader in the design and manufacturing of innovative solutions for injectable drug administration. Founded in 1923 and headquartered in Exton, Pennsylvania, the company has a rich history of nearly a century in providing high-quality, reliable products to the pharmaceutical and healthcare industries. West Pharmaceutical Services operates in over 50 locations worldwide, employing thousands of professionals dedicated to advancing healthcare delivery.

The company’s leadership team is spearheaded by Eric M. Green, who serves as President and Chief Executive Officer. Under his guidance, West has continued to innovate and expand its portfolio, maintaining its position as a trusted partner to pharmaceutical and biotechnology companies globally. The company’s commitment to quality, innovation, and sustainability has been a cornerstone of its success.

Core Business Segments

West Pharmaceutical Services operates through two primary business segments: Proprietary Products and Contract-Manufactured Products.

Proprietary Products

This segment focuses on the development and manufacturing of proprietary components and systems for injectable drug delivery. Key offerings include:

  • Plungers and Stoppers: High-quality elastomer components used in syringes, vials, and cartridges to ensure drug integrity and patient safety.
  • Daikyo Crystal Zenith®: A cyclic olefin polymer-based alternative to glass, offering superior performance for sensitive biologics.
  • Westar® Components: Ready-to-use components that reduce contamination risks and improve operational efficiency.
  • Self-Injection Systems: Innovative devices like the SmartDose® platform, which enables patients to self-administer medication conveniently and accurately.

Contract-Manufactured Products

This segment provides contract manufacturing services for pharmaceutical and medical device companies. Key offerings include:

  • Medical Device Components: Precision-molded components for diagnostic and drug delivery devices.
  • Combination Products: Integrated solutions that combine drug and device technologies, such as prefilled syringes and auto-injectors.
  • Custom Manufacturing: Tailored solutions to meet specific client needs, leveraging West’s expertise in materials science and engineering.

Business Model

West Pharmaceutical Services operates a vertically integrated business model that combines product innovation, manufacturing excellence, and customer-centric services. The company generates revenue through the sale of proprietary products, contract manufacturing services, and value-added solutions such as analytical testing and regulatory support.

West’s approach emphasizes long-term partnerships with pharmaceutical and biotechnology companies. By collaborating closely with clients, West ensures that its products and services align with the evolving needs of the healthcare industry. The company’s focus on quality, reliability, and innovation has enabled it to build a loyal customer base and achieve consistent revenue growth.

Strategic Direction

West Pharmaceutical Services is committed to driving growth through innovation, sustainability, and global expansion. Key strategic priorities include:

  • Innovation: Investing in research and development to create next-generation drug delivery systems and materials. Recent initiatives include the development of digital health solutions and smart packaging technologies.
  • Sustainability: Reducing the environmental impact of its operations through energy efficiency, waste reduction, and sustainable sourcing. West has set ambitious goals to achieve carbon neutrality and minimize its ecological footprint.
  • Global Expansion: Strengthening its presence in emerging markets and expanding manufacturing capacity to meet growing demand. The company is also focused on enhancing its supply chain resilience to mitigate risks.

Competitive Landscape

West Pharmaceutical Services operates in a competitive market, facing challenges from both established players and emerging companies. Key competitors include:

  • Gerresheimer AG: A leading provider of glass and plastic packaging solutions for the pharmaceutical industry.
  • Schott AG: Known for its high-quality glass products, including vials and syringes.
  • AptarGroup, Inc.: Specializes in drug delivery systems and dispensing solutions.
  • BD (Becton, Dickinson and Company): A global leader in medical technology, offering a wide range of drug delivery devices.

Despite the competition, West differentiates itself through its focus on innovation, quality, and customer service. The company’s proprietary technologies and strong client relationships provide a competitive edge.

Risk Factors

West Pharmaceutical Services faces several risks that could impact its business performance:

  • Market Dependence: A significant portion of revenue comes from a limited number of large pharmaceutical clients. Any changes in these relationships could affect financial stability.
  • Supply Chain Disruptions: Dependence on raw materials and global supply chains exposes the company to risks such as delays, price fluctuations, and geopolitical tensions.
  • Regulatory Compliance: The highly regulated nature of the pharmaceutical industry requires strict adherence to quality and safety standards. Non-compliance could result in fines, recalls, or reputational damage.
  • Technological Disruption: Rapid advancements in drug delivery technologies could render existing products obsolete, necessitating continuous innovation.

Recent Developments

West Pharmaceutical Services has made significant strides in recent years, including:

  • Product Innovations: Launching new self-injection systems and smart packaging solutions to enhance patient convenience and adherence.
  • Sustainability Initiatives: Implementing energy-efficient manufacturing processes and achieving milestones in waste reduction.
  • Global Expansion: Opening new facilities in Asia and Europe to meet growing demand and improve supply chain resilience.
  • Digital Transformation: Leveraging data analytics and automation to optimize operations and enhance customer experiences.

The COVID-19 pandemic also highlighted West’s critical role in the healthcare ecosystem, as the company supplied components for vaccines and treatments.

Investment Considerations

Investors considering West Pharmaceutical Services should weigh the following factors:

Strengths

  • Market Leadership: A trusted partner to leading pharmaceutical and biotechnology companies.
  • Innovation-Driven Growth: Strong focus on R&D and new product development.
  • Global Presence: Extensive manufacturing and distribution network.
  • Sustainability Commitment: Proactive approach to environmental and social responsibility.

Risks

  • Client Concentration: Dependence on a few large clients for a significant portion of revenue.
  • Regulatory Challenges: Exposure to stringent regulatory requirements and potential compliance risks.
  • Market Volatility: Vulnerability to economic downturns and changes in healthcare spending.

Conclusion

West Pharmaceutical Services, Inc. is a market leader in injectable drug delivery solutions, with a strong track record of innovation and customer satisfaction. The company’s commitment to quality, sustainability, and global expansion positions it well for future growth. While challenges such as supply chain risks and regulatory compliance remain, West’s strategic initiatives and robust business model provide a solid foundation for long-term success.